meglumine has been researched along with Acute-On-Chronic Liver Failure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, C; Liu, K; Ma, H; Shen, Z; Wang, X; Zhao, X; Zhu, Q | 1 |
1 other study(ies) available for meglumine and Acute-On-Chronic Liver Failure
| Article | Year |
|---|---|
Gd-BOPTA-enhanced hepatobiliary phase MR imaging can predict the prognosis of patients with acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Contrast Media; Gadolinium DTPA; Humans; Liver; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Prognosis; Retrospective Studies | 2022 |